Cargando…
Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergies
BACKGROUND: The progression rates of Alzheimer’s disease (AD) are variable and dynamic, yet the mechanisms that contribute to heterogeneity in progression rates remain ill-understood. Particularly, the role of synergies in pathological processes reflected by biomarkers for amyloid-beta (‘A’), tau (‘...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787915/ https://www.ncbi.nlm.nih.gov/pubmed/35073974 http://dx.doi.org/10.1186/s13195-021-00941-1 |